725 related articles for article (PubMed ID: 36001803)
1. Genomic profiling for clinical decision making in lymphoid neoplasms.
de Leval L; Alizadeh AA; Bergsagel PL; Campo E; Davies A; Dogan A; Fitzgibbon J; Horwitz SM; Melnick AM; Morice WG; Morin RD; Nadel B; Pileri SA; Rosenquist R; Rossi D; Salaverria I; Steidl C; Treon SP; Zelenetz AD; Advani RH; Allen CE; Ansell SM; Chan WC; Cook JR; Cook LB; d'Amore F; Dirnhofer S; Dreyling M; Dunleavy K; Feldman AL; Fend F; Gaulard P; Ghia P; Gribben JG; Hermine O; Hodson DJ; Hsi ED; Inghirami G; Jaffe ES; Karube K; Kataoka K; Klapper W; Kim WS; King RL; Ko YH; LaCasce AS; Lenz G; Martin-Subero JI; Piris MA; Pittaluga S; Pasqualucci L; Quintanilla-Martinez L; Rodig SJ; Rosenwald A; Salles GA; San-Miguel J; Savage KJ; Sehn LH; Semenzato G; Staudt LM; Swerdlow SH; Tam CS; Trotman J; Vose JM; Weigert O; Wilson WH; Winter JN; Wu CJ; Zinzani PL; Zucca E; Bagg A; Scott DW
Blood; 2022 Nov; 140(21):2193-2227. PubMed ID: 36001803
[TBL] [Abstract][Full Text] [Related]
2. Towards precision medicine in lymphoid malignancies.
Bühler MM; Martin-Subero JI; Pan-Hammarström Q; Campo E; Rosenquist R
J Intern Med; 2022 Aug; 292(2):221-242. PubMed ID: 34875132
[TBL] [Abstract][Full Text] [Related]
3. Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
Campo E
Mod Pathol; 2013 Jan; 26 Suppl 1():S97-S110. PubMed ID: 23281439
[TBL] [Abstract][Full Text] [Related]
4. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
5. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Duncavage EJ; Bagg A; Hasserjian RP; DiNardo CD; Godley LA; Iacobucci I; Jaiswal S; Malcovati L; Vannucchi AM; Patel KP; Arber DA; Arcila ME; Bejar R; Berliner N; Borowitz MJ; Branford S; Brown AL; Cargo CA; Döhner H; Falini B; Garcia-Manero G; Haferlach T; Hellström-Lindberg E; Kim AS; Klco JM; Komrokji R; Lee-Cheun Loh M; Loghavi S; Mullighan CG; Ogawa S; Orazi A; Papaemmanuil E; Reiter A; Ross DM; Savona M; Shimamura A; Skoda RC; Solé F; Stone RM; Tefferi A; Walter MJ; Wu D; Ebert BL; Cazzola M
Blood; 2022 Nov; 140(21):2228-2247. PubMed ID: 36130297
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
Rosenquist R; Rosenwald A; Du MQ; Gaidano G; Groenen P; Wotherspoon A; Ghia P; Gaulard P; Campo E; Stamatopoulos K;
Haematologica; 2016 Sep; 101(9):1002-9. PubMed ID: 27582569
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
[TBL] [Abstract][Full Text] [Related]
10. [Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
Shingaki S; Kataoka K
Rinsho Ketsueki; 2022; 63(9):1058-1066. PubMed ID: 36198530
[TBL] [Abstract][Full Text] [Related]
11. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
[TBL] [Abstract][Full Text] [Related]
12. New insights into the diagnosis of lymphomas.
Soldini D; Campo E
Ann Oncol; 2012 Sep; 23 Suppl 10():x83-8. PubMed ID: 22987998
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
14. The 2022 classifications of lymphoid neoplasms : Keynote.
Campo E
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):121-127. PubMed ID: 37957421
[TBL] [Abstract][Full Text] [Related]
15. Genome sequencing of lymphoid malignancies.
Mullighan CG
Blood; 2013 Dec; 122(24):3899-907. PubMed ID: 24041576
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling for precision cancer therapies.
Malone ER; Oliva M; Sabatini PJB; Stockley TL; Siu LL
Genome Med; 2020 Jan; 12(1):8. PubMed ID: 31937368
[TBL] [Abstract][Full Text] [Related]
17. The role of molecular biology in the diagnosis of lymphoid neoplasms.
Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
[TBL] [Abstract][Full Text] [Related]
18. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
Surrey LF; Luo M; Chang F; Li MM
Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
[TBL] [Abstract][Full Text] [Related]
19. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Campo E; Jaffe ES; Cook JR; Quintanilla-Martinez L; Swerdlow SH; Anderson KC; Brousset P; Cerroni L; de Leval L; Dirnhofer S; Dogan A; Feldman AL; Fend F; Friedberg JW; Gaulard P; Ghia P; Horwitz SM; King RL; Salles G; San-Miguel J; Seymour JF; Treon SP; Vose JM; Zucca E; Advani R; Ansell S; Au WY; Barrionuevo C; Bergsagel L; Chan WC; Cohen JI; d'Amore F; Davies A; Falini B; Ghobrial IM; Goodlad JR; Gribben JG; Hsi ED; Kahl BS; Kim WS; Kumar S; LaCasce AS; Laurent C; Lenz G; Leonard JP; Link MP; Lopez-Guillermo A; Mateos MV; Macintyre E; Melnick AM; Morschhauser F; Nakamura S; Narbaitz M; Pavlovsky A; Pileri SA; Piris M; Pro B; Rajkumar V; Rosen ST; Sander B; Sehn L; Shipp MA; Smith SM; Staudt LM; Thieblemont C; Tousseyn T; Wilson WH; Yoshino T; Zinzani PL; Dreyling M; Scott DW; Winter JN; Zelenetz AD
Blood; 2022 Sep; 140(11):1229-1253. PubMed ID: 35653592
[TBL] [Abstract][Full Text] [Related]
20. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
